(SSY) SunLink Health Systems - Ratings and Ratios

Exchange: NYSE MKT • Country: United States • Currency: USD • Type: Common Stock • ISIN: US86737U1025

SSY: Healthcare Services, Pharmacy Products, Medical Equipment, IT Services

SunLink Health Systems, Inc. operates as a healthcare services provider in the southeastern United States, focusing on institutional and non-institutional care settings. Through its subsidiaries, the company delivers a range of healthcare products and services, including specialty and non-specialty pharmaceuticals, biological products, durable medical equipment, and IT solutions. Its customer base includes nursing homes, assisted living facilities, behavioral and specialty hospitals, hospices, correctional facilities, and private residences. The company also provides retail pharmacy products and services. Additionally, SunLink owns 3.73 acres of unimproved land and offers IT services to support its operations. Incorporated in 1959 and headquartered in Atlanta, Georgia, the company trades on the NYSE MKT under the ticker symbol SSY and is classified under the Health Care Facilities industry.

Based on the provided and , the 3-month forecast for SunLink Health Systems, Inc. (SSY) is as follows. Technically, the stock is currently trading below its 20-day and 50-day moving averages (SMA 20: 0.97, SMA 50: 0.95) but above its 200-day moving average (SMA 200: 0.83). This suggests short-term weakness but long-term stability. The average true range (ATR) of 0.08 indicates manageable volatility. Fundamentally, the company’s market cap of $6.05M reflects its small size, while its P/B ratio of 0.51 and P/S ratio of 0.23 suggest undervaluation relative to book value and sales. The return on equity (RoE) of 7.10% indicates moderate profitability. Over the next three months, expect the stock to trade in a narrow range between $0.80 and $1.10, driven by its current technical setup and fundamental valuations.

Additional Sources for SSY Stock

SSY Stock Overview

Market Cap in USD 6m
Sector Healthcare
Industry Pharmaceutical Retailers
GiC Sub-Industry Health Care Facilities
IPO / Inception 1990-03-26

SSY Stock Ratings

Growth Rating 5.61
Fundamental -36.6
Dividend Rating 1.31
Rel. Strength 32.1
Analysts -
Fair Price Momentum 0.85 USD
Fair Price DCF -

SSY Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y 0.00%
Payout Consistency 5.3%

SSY Growth Ratios

Growth Correlation 3m 25.7%
Growth Correlation 12m 77.2%
Growth Correlation 5y -56%
CAGR 5y 4.85%
CAGR/Max DD 5y 0.06
Sharpe Ratio 12m -0.04
Alpha 25.41
Beta 0.682
Volatility 110.66%
Current Volume 0k
Average Volume 20d 14k
What is the price of SSY stocks?
As of April 19, 2025, the stock is trading at USD 0.91 with a total of 0 shares traded.
Over the past week, the price has changed by +1.82%, over one month by -3.60%, over three months by -2.82% and over the past year by +31.33%.
Is SunLink Health Systems a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, SunLink Health Systems (NYSE MKT:SSY) is currently (April 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -36.64 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SSY as of April 2025 is 0.85. This means that SSY is currently overvalued and has a potential downside of -6.59%.
Is SSY a buy, sell or hold?
SunLink Health Systems has no consensus analysts rating.
What are the forecast for SSY stock price target?
According to ValueRays Forecast Model, SSY SunLink Health Systems will be worth about 0.9 in April 2026. The stock is currently trading at 0.91. This means that the stock has a potential upside of +2.2%.
Issuer Forecast Upside
Wallstreet Target Price 2.4 158.2%
Analysts Target Price - -
ValueRay Target Price 0.9 2.2%